JUVÉDERM VOLUMA™ XC is the first and only gel injection filler to correct age-related volume loss in the cheek area*.

Juvederm_VolumaXC logo 4c

Skin Envy Surgery is one of the first medical practice in the Austin, TX area to offer the first and only filler to temporarily correct age-related volume loss in the cheek area. Recently approved by the FDA, JUVÉDERM VOLUMA™ XC is a non-surgical treatment that helps create a more youthful appearance and provides natural-looking results that last up to two years.

Wrinkles are only part of the aging equation.

Volume loss in the cheeks is a major reason we lose that youthful profile over the years.


*Individual results may vary.

As people age, the cheek area can lose volume, causing the cheeks to flatten out and the skin to droop and sag. Age-related facial volume loss is a growing need in the field of aesthetic medicine. The 2013 American Society for Dermatological Surgery (ASDS) Consumer Survey on Cosmetic Procedures revealed that one of the top reasons why people choose to undergo a cosmetic procedure is because they want to look as young as they feel, with sixty-one percent of respondents most bothered by sagging facial skin.

*Individual results may vary.


JUVÉDERM VOLUMA™ XC is injected under the skin with a small needle. It works instantly to add volume and subtly lift the cheek area, temporarily reversing this sign of aging. To reduce pain during the procedure, JUVÉDERM VOLUMA™ XC contains a numbing agent called lidocaine. The more youthful profile you can achieve from the procedure lasts up to 2 years with optimal treatment.

"Until now, there were no effective non-surgical options for treating the cheek area of the face. With JUVÉDERM VOLUMA™ XC you have relatively little recovery or downtime and instant results you can see before you leave our office."

Call 512-424-4247 for more information and to schedule an appointment.

In the clinical study, people perceived themselves to look 5 years younger 6 months after treatment, and  3 years younger 24 months after treatment.* The average volume injected during the clinical study was 6.8 mL to achieve optimal correction for the cheek area.

*Individual results may vary.